News Archives

June 29, 2010

Lead Author of Upcoming FDA Study on Avandia Says Drug Should be Banned

FDA scientist Dr. David Graham, the lead author of a huge study on Avandia involving over 227,571 Medicare patients from 2006-2009, says the popular Type-2 diabetes mediation Avandia should be banned due to a high risk of heart problems, stroke, and deaths.  As many as 100,000 injuries and deaths have been linked to Avandia since its release in...

Read More

May 12, 2010

New Program Urges Doctors to Report Illegal Drug Promotions

According to the Congressional Budget Office, the pharmaceutical industry spends nearly three times as much on advertising to health care professionals as they do advertising to consumers. The FDA's Division of Drug Marketing, Advertising and Communications announced yesterday the implementation of the "Bad Ad Program" which is part of a wider...

Read More

April 28, 2010

Drug Giant Astrazeneca to Pay Record $520 Million for Off-Label Drug Promotion

The Department of Justice and the U.S. Department of Health & Human Services’ Health Care Fraud Enforcement Action Team announced yesterday that drug giant Astrazeneca will pay $520 million to settle a civil settlement to resolve allegations that it illegally marketed and promoted the anti-psychotic drug Seroquel (a drug targeted for...

Read More

March 20, 2010

FDA Issues Public Safety Announcement on Popular Cholesterol Medication Zocor

Zocor (simvastatin) is a prescription medication that has been used by millions of Americans to help lower high cholesterol and prevent cardiovascular disease.  On March 19, 2010, the FDA released a public Safety Announcement regarding increased safety risks for patients who take the 80 milligram dose of Zocor (the highest approved dosage of...

Read More

January 22, 2010

FDA Issues Alert on Weight-Loss Drug Meridia

On January 21, 2010 the FDA issued a warning to healthcare professionals regarding the weight-loss drug Meridia (Abbott Laboratories). The warning comes after a review of additional data from a trial known as SCOUT showed an increased risk of heart attack and stroke among patients taking Meridia who have a history of cardiovascular disease....

Read More

January 11, 2010

Study Indicates Nursing Home Residents Over-Prescribed Antipsychotic Drugs

A new study published in the January 2010 Archives of Internal Medicine (Yong Chen, M.D., University of Massachusetts Medical School) indicates that nearly 30% of nursing home residents from across the United States were prescribed antipsychotic drugs and nearly one-third of these persons had no medical need for the drugs.  The study is concerning...

Read More

October 3, 2009

Genetic Testing Information to be protected under new HHS regulations

The U.S. Departments of Health and Human Services (HHS), Labor, and the Treasury announced that patients' genetic health information will have greater protections under new regulations issued earlier this week. Under Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA) and the new interim final regulations, group health plans and...

Read More

Best Law Firms Badge 2010 Best Law Firms Badge 2011-2012 Best Law Firms Badge 2013 Best Law Firms Badge 2014 Best Law Firms Badge 2015 Listed in Best Lawyers 2015 2015 Legal Leaders - Top Rated Lawyers Best Law Firms Badge 2016 American Board of Trial Advocates
Super Lawyers Badge for C. Todd Alley Super Lawyers Badge for Don Greiwe Super Lawyers Badge for James D. Clark National Board of Trial Advocacy Badge The National Trial Lawyers Badge 2015 Bay Area Legal Sustaining Law Firm
AV Preeminent Badge for James D. Clark AV Preeminent Badge for Donald G. Greiwe AV Preeminent Badge for C. Todd Alley AV Preeminent Badge for Alley, Clark & Greiwe

Contact Us

Alley, Clark & Greiwe

Street Address
201 N. Franklin, 7th Floor,
Tampa, FL 33602

General Email Inquiries:

Call Us 1-813-222-0977

P (813) 222-0977 | F (813) 224-0373

Free Case Evaluation